Marcar, L., Bardhan, K., Gheorghiu, L., Dinkelborg, P., Pfäffle, H., Liu, Q., . . . Willers, H. (2019). Acquired Resistance of EGFR-Mutated Lung Cancer to Tyrosine Kinase Inhibitor Treatment Promotes PARP Inhibitor Sensitivity. Cell Rep.
Citação norma ChicagoMarcar, Lynnette, et al. "Acquired Resistance of EGFR-Mutated Lung Cancer to Tyrosine Kinase Inhibitor Treatment Promotes PARP Inhibitor Sensitivity." Cell Rep 2019.
Citação norma MLAMarcar, Lynnette, et al. "Acquired Resistance of EGFR-Mutated Lung Cancer to Tyrosine Kinase Inhibitor Treatment Promotes PARP Inhibitor Sensitivity." Cell Rep 2019.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.